Elana S. Ehrlich

1.4k total citations
19 papers, 1.2k citations indexed

About

Elana S. Ehrlich is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Elana S. Ehrlich has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Virology and 6 papers in Infectious Diseases. Recurrent topics in Elana S. Ehrlich's work include HIV Research and Treatment (8 papers), Ubiquitin and proteasome pathways (7 papers) and HIV/AIDS drug development and treatment (6 papers). Elana S. Ehrlich is often cited by papers focused on HIV Research and Treatment (8 papers), Ubiquitin and proteasome pathways (7 papers) and HIV/AIDS drug development and treatment (6 papers). Elana S. Ehrlich collaborates with scholars based in United States, China and Italy. Elana S. Ehrlich's co-authors include Xiao-Fang Yu, Zuoxiang Xiao, Yunkai Yu, Kun Luo, Xianghui Yu, Lindi Tan, Bindong Liu, Shu Zheng, Xiao‐Fang Yu and Yong Xiong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and The Journal of Immunology.

In The Last Decade

Elana S. Ehrlich

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elana S. Ehrlich United States 15 754 499 466 398 314 19 1.2k
Michael D. Moore United States 17 536 0.7× 289 0.6× 427 0.9× 453 1.1× 288 0.9× 22 1.2k
Fabio Romerio United States 21 844 1.1× 447 0.9× 603 1.3× 726 1.8× 217 0.7× 50 1.6k
Simon Swingler United States 11 1.2k 1.5× 630 1.3× 425 0.9× 574 1.4× 278 0.9× 13 1.5k
Robert E. Atchison United States 14 915 1.2× 436 0.9× 430 0.9× 883 2.2× 208 0.7× 14 1.5k
Farida Shaheen United States 16 485 0.6× 365 0.7× 516 1.1× 364 0.9× 211 0.7× 22 1.2k
Aram Mangasarian Germany 9 766 1.0× 318 0.6× 250 0.5× 547 1.4× 232 0.7× 14 1.1k
Kasinath Viswanathan United States 16 468 0.6× 215 0.4× 431 0.9× 467 1.2× 446 1.4× 26 1.3k
Benjamin Descours France 12 959 1.3× 446 0.9× 254 0.5× 884 2.2× 337 1.1× 19 1.5k
Ashley P. Barry United States 15 686 0.9× 244 0.5× 262 0.6× 609 1.5× 290 0.9× 20 1.1k
Diana Ayinde France 11 989 1.3× 395 0.8× 392 0.8× 690 1.7× 371 1.2× 11 1.3k

Countries citing papers authored by Elana S. Ehrlich

Since Specialization
Citations

This map shows the geographic impact of Elana S. Ehrlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elana S. Ehrlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elana S. Ehrlich more than expected).

Fields of papers citing papers by Elana S. Ehrlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elana S. Ehrlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elana S. Ehrlich. The network helps show where Elana S. Ehrlich may publish in the future.

Co-authorship network of co-authors of Elana S. Ehrlich

This figure shows the co-authorship network connecting the top 25 collaborators of Elana S. Ehrlich. A scholar is included among the top collaborators of Elana S. Ehrlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elana S. Ehrlich. Elana S. Ehrlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Masters, Brian S., et al.. (2024). Analysis of the ubiquitin-modified proteome identifies novel host factors in Kaposi’s sarcoma herpesvirus lytic reactivation. Journal of Virology. 99(1). e0122424–e0122424. 1 indexed citations
2.
Ehrlich, Elana S., et al.. (2023). E3 Ubiquitin Ligases in Gammaherpesviruses and HIV: A Review of Virus Adaptation and Exploitation. Viruses. 15(9). 1935–1935. 5 indexed citations
3.
Zheng, Zheng, et al.. (2019). Gold nanoparticles loaded with cullin-5 DNA increase sensitivity to 17-AAG in cullin-5 deficient breast cancer cells. International Journal of Pharmaceutics. 564. 281–292. 14 indexed citations
4.
Choi, Young Bong, et al.. (2016). The Itch ubiquitin ligase is required for KSHV RTA induced vFLIP degradation. Virology. 501. 119–126. 14 indexed citations
5.
Ehrlich, Elana S., et al.. (2014). KSHV RTA Abolishes NFκB Responsive Gene Expression during Lytic Reactivation by Targeting vFLIP for Degradation via the Proteasome. PLoS ONE. 9(3). e91359–e91359. 30 indexed citations
6.
Li, Zhaolong, Jinghua Yu, Li Liu, et al.. (2014). Coxsackievirus A16 Infection Induces Neural Cell and Non-Neural Cell Apoptosis In Vitro. PLoS ONE. 9(10). e111174–e111174. 18 indexed citations
7.
Ehrlich, Elana S., Kun Luo, Zuoxiang Xiao, et al.. (2009). Regulation of Hsp90 client proteins by a Cullin5-RING E3 ubiquitin ligase. Proceedings of the National Academy of Sciences. 106(48). 20330–20335. 104 indexed citations
8.
Ehrlich, Elana S., et al.. (2008). E1B 55k-independent dissociation of the DNA ligase IV/XRCC4 complex by E4 34k during adenovirus infection. Virology. 382(2). 163–170. 15 indexed citations
9.
Stanley, Bradford, Elana S. Ehrlich, Yunkai Yu, et al.. (2008). Structural Insight into the Human Immunodeficiency Virus Vif SOCS Box and Its Role in Human E3 Ubiquitin Ligase Assembly. Journal of Virology. 82(17). 8656–8663. 95 indexed citations
10.
Tan, Lindi, Elana S. Ehrlich, & Xiao-Fang Yu. (2007). DDB1 and Cul4A Are Required for Human Immunodeficiency Virus Type 1 Vpr-Induced G 2 Arrest. Journal of Virology. 81(19). 10822–10830. 108 indexed citations
11.
Xiao, Zuoxiang, Yong Xiong, Wenyan Zhang, et al.. (2007). Characterization of a Novel Cullin5 Binding Domain in HIV-1 Vif. Journal of Molecular Biology. 373(3). 541–550. 49 indexed citations
12.
Luo, Kun, Elana S. Ehrlich, Zuoxiang Xiao, et al.. (2007). Adenovirus E4orf6 assembles with Cullin5‐ElonginB‐ElonginC E3 ubiquitin ligase through an HIV/SIV Vif‐like BC‐box to regulate p53. The FASEB Journal. 21(8). 1742–1750. 43 indexed citations
13.
Xiao, Zuoxiang, Elana S. Ehrlich, Yunkai Yu, et al.. (2006). Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif. Virology. 349(2). 290–299. 115 indexed citations
14.
Ehrlich, Elana S. & Xiao-Fang Yu. (2006). Lentiviral Vif: Viral Hijacker of the Ubiquitin-Proteasome System. International Journal of Hematology. 83(3). 208–212. 15 indexed citations
15.
Xiao, Zuoxiang, Elana S. Ehrlich, Kun Luo, Yong Xiong, & Xiao‐Fang Yu. (2006). Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G. The FASEB Journal. 21(1). 217–222. 73 indexed citations
16.
Luo, Kun, Zuoxiang Xiao, Elana S. Ehrlich, et al.. (2005). Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5–E3 ligase through a HCCH motif to suppress APOBEC3G. Proceedings of the National Academy of Sciences. 102(32). 11444–11449. 158 indexed citations
17.
Yu, Yunkai, Zuoxiang Xiao, Elana S. Ehrlich, Xianghui Yu, & Xiao-Fang Yu. (2004). Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes & Development. 18(23). 2867–2872. 262 indexed citations
18.
Boisgérault, Florence, Ying Liu, Natalie G. Anosova, et al.. (2001). Role of CD4+ and CD8+ T Cells in Allorecognition: Lessons from Corneal Transplantation. The Journal of Immunology. 167(4). 1891–1899. 100 indexed citations
19.
Chapman, Ralph E., et al.. (1977). Evidence for Long-Range Effects in Density-Dependent Inhibition of Proliferation (DDIP) in 3T3 Cells. Differentiation. 9(1-3). 157–160. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026